Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott W Lowe

Showing results (301-310 of 321) with videos related to

Pageof 33
Sort By:
Cell|August 14, 2018
Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear ImportVeronica Rodriguez-Bravo, Raffaella Pippa, Won-Min Song, et al.
Cancer Cell|March 30, 2020
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin DysregulationZeda Zhang, Chuanli Zhou, Xiaoling Li, et al.
Immunity|July 1, 2018
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to ImmunotherapyJinyang Li, Katelyn T Byrne, Fangxue Yan, et al.
Nature|December 15, 2015
The histone chaperone CAF-1 safeguards somatic cell identitySihem Cheloufi, Ulrich Elling, Barbara Hopfgartner, et al.
Immunity|November 22, 2024
Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanismsSiyu Sun, Eunae You, Jungeui Hong, et al.
Cancer Discovery|September 23, 2021
<i>MYC</i> Levels Regulate Metastatic Heterogeneity in Pancreatic AdenocarcinomaRavikanth Maddipati, Robert J Norgard, Timour Baslan, et al.
Journal of the National Cancer Institute|April 1, 2021
Therapy-Induced Senescence: Opportunities to Improve Anticancer TherapyPataje G Prasanna, Deborah E Citrin, Jeffrey Hildesheim, et al.
Cancer Discovery|November 10, 2022
Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal CancerRona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, et al.
Genome Biology|September 16, 2011
Mutation discovery in mice by whole exome sequencingHeather Fairfield, Griffith J Gilbert, Mary Barter, et al.
Nature Cancer|April 22, 2022
KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogrammingFeifei Na, Xiangyu Pan, Jingyao Chen, et al.
Pageof 33

Showing results (301-310 of 321) with videos related to

Sort By:
Pageof 33
Cell|August 14, 2018
Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear ImportVeronica Rodriguez-Bravo, Raffaella Pippa, Won-Min Song, et al.
Cancer Cell|March 30, 2020
Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin DysregulationZeda Zhang, Chuanli Zhou, Xiaoling Li, et al.
Immunity|July 1, 2018
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to ImmunotherapyJinyang Li, Katelyn T Byrne, Fangxue Yan, et al.
Nature|December 15, 2015
The histone chaperone CAF-1 safeguards somatic cell identitySihem Cheloufi, Ulrich Elling, Barbara Hopfgartner, et al.
Immunity|November 22, 2024
Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanismsSiyu Sun, Eunae You, Jungeui Hong, et al.
Cancer Discovery|September 23, 2021
<i>MYC</i> Levels Regulate Metastatic Heterogeneity in Pancreatic AdenocarcinomaRavikanth Maddipati, Robert J Norgard, Timour Baslan, et al.
Journal of the National Cancer Institute|April 1, 2021
Therapy-Induced Senescence: Opportunities to Improve Anticancer TherapyPataje G Prasanna, Deborah E Citrin, Jeffrey Hildesheim, et al.
Cancer Discovery|November 10, 2022
Molecular Characterization of Acquired Resistance to KRASG12C-EGFR Inhibition in Colorectal CancerRona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, et al.
Genome Biology|September 16, 2011
Mutation discovery in mice by whole exome sequencingHeather Fairfield, Griffith J Gilbert, Mary Barter, et al.
Nature Cancer|April 22, 2022
KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogrammingFeifei Na, Xiangyu Pan, Jingyao Chen, et al.
Pageof 33